ImmunoGen Inc (NASDAQ:IMGN)

11.19
Delayed Data
As of Feb 23
 +0.33 / +3.04%
Today’s Change
2.43
Today|||52-Week Range
12.05
+74.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues28.5M39.0M8.5M39.4M
 
 
 
 
 
Depreciation And Amortization1.5M1.4M1.4M--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses39.5M42.7M38.2M48.9M
 
 
 
 
 
Research And Development32.9M35.3M31.7M39.8M
 
 
 
 
 
Total Operating Expenses41.0M44.2M39.6M48.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.5M-5.1M-31.1M-9.4M
 
 
 
 
 
Extraordinary Charge-386.0K---22.2M-1.1M
 
 
 
 
Interest Expense On Debt4.7M4.6M4.1M3.2M
 
 
 
 
 
Other Expenses134.0K751.0K480.0K691.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.3M-8.9M-56.7M-13.1M
 
 
 
 
 
Net Income-17.3M-8.9M-56.7M-13.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS87.2M87.2M93.0M--
 
 
 
 
Shares To Calculate EPS Diluted87.2M87.2M93.0M124.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.10-$0.61-$0.11
 
 
 
 
 
EPS Diluted-$0.20-$0.10-$0.61-$0.11